129 related articles for article (PubMed ID: 36796547)
1. Clinical and biochemical short-term effects of hyperbaric oxygen therapy on SARS-Cov-2+ hospitalized patients with hypoxemic respiratory failure.
Keller GA; Colaianni I; Coria J; Di Girolamo G; Miranda S
Respir Med; 2023 Apr; 209():107155. PubMed ID: 36796547
[TBL] [Abstract][Full Text] [Related]
2. Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
Meroni PL; Croci S; Lonati PA; Pregnolato F; Spaggiari L; Besutti G; Bonacini M; Ferrigno I; Rossi A; Hetland G; Hollan I; Cugno M; Tedesco F; Borghi MO; Salvarani C
Autoimmun Rev; 2023 Jan; 22(1):103232. PubMed ID: 36414219
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Hyperbaric Oxygen Therapy in SARS-CoV-2 Pneumonia: The Primary Results of a Randomised Clinical Trial.
Siewiera J; Brodaczewska K; Jermakow N; Lubas A; Kłos K; Majewska A; Kot J
J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614808
[TBL] [Abstract][Full Text] [Related]
4. Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series.
Thibodeaux K; Speyrer M; Raza A; Yaakov R; Serena TE
J Wound Care; 2020 May; 29(Sup5a):S4-S8. PubMed ID: 32412891
[TBL] [Abstract][Full Text] [Related]
5. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J
Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].
Xu Y; Qian Y; Gu Q; Tang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):559-563. PubMed ID: 32576347
[TBL] [Abstract][Full Text] [Related]
7. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
9. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review.
Oliaei S; SeyedAlinaghi S; Mehrtak M; Karimi A; Noori T; Mirzapour P; Shojaei A; MohsseniPour M; Mirghaderi SP; Alilou S; Shobeiri P; Azadi Cheshmekabodi H; Mehraeen E; Dadras O
Eur J Med Res; 2021 Aug; 26(1):96. PubMed ID: 34412709
[TBL] [Abstract][Full Text] [Related]
10. Hyperbaric oxygenation therapy alleviates chronic constrictive injury-induced neuropathic pain and reduces tumor necrosis factor-alpha production.
Li F; Fang L; Huang S; Yang Z; Nandi J; Thomas S; Chen C; Camporesi E
Anesth Analg; 2011 Sep; 113(3):626-33. PubMed ID: 21596875
[TBL] [Abstract][Full Text] [Related]
11. Effects of hyperbaric oxygen and dexamethasone on proinflammatory cytokines of rat cochlea in noise-induced hearing loss.
Arslan HH; Satar B; Serdar MA; Ozler M; Yilmaz E
Otol Neurotol; 2012 Dec; 33(9):1672-8. PubMed ID: 23007643
[TBL] [Abstract][Full Text] [Related]
12. Effect of Hyperbaric oxygen on myelin injury and repair after hypoxic-ischemic brain damage in adult rat.
Xue R; Pan S; Guo D
Neurosci Lett; 2023 Jan; 794():137015. PubMed ID: 36526030
[TBL] [Abstract][Full Text] [Related]
13. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
14. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
15. Early prolonged prone position in noninvasively ventilated patients with SARS-CoV-2-related moderate-to-severe hypoxemic respiratory failure: clinical outcomes and mechanisms for treatment response in the PRO-NIV study.
Musso G; Taliano C; Molinaro F; Fonti C; Veliaj D; Torti D; Paschetta E; Castagna E; Carbone G; Laudari L; Aseglio C; Zocca E; Chioni S; Giannone LC; Arabia F; Deiana C; Benato FM; Druetta M; Campagnola G; Borsari M; Mucci M; Rubatto T; Peyronel M; Tirabassi G
Crit Care; 2022 Apr; 26(1):118. PubMed ID: 35488356
[TBL] [Abstract][Full Text] [Related]
16. Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management.
Antony SJ; Davis MA; Davis MG; Almaghlouth NK; Guevara R; Omar F; Del Rey F; Hassan A; Arian MU; Antony N; Prakash BV
J Med Virol; 2021 Jan; 93(1):491-498. PubMed ID: 32644254
[TBL] [Abstract][Full Text] [Related]
17. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
[TBL] [Abstract][Full Text] [Related]
18. Can Hyperbaric Oxygen Therapy Be Used to Treat Children after COVID-19? A Bibliographic Review.
Myśliwiec AP; Walatek JT; Tarnawa A; Nierwińska K; Doroniewicz I
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429932
[TBL] [Abstract][Full Text] [Related]
19. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
[TBL] [Abstract][Full Text] [Related]
20. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
Fiotti N; Giansante C; Ponte E; Delbello C; Calabrese S; Zacchi T; Dobrina A; Guarnieri G
Atherosclerosis; 1999 Jul; 145(1):51-60. PubMed ID: 10428295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
